Last reviewed · How we verify
Aripiprazole with Clozapine
At a glance
| Generic name | Aripiprazole with Clozapine |
|---|---|
| Also known as | Aripiprazole Tablets |
| Sponsor | Shanghai Mental Health Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine (PHASE4)
- Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. (PHASE4)
- Magnetic Seizure Therapy for Psychotic Disorders (NA)
- Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT) (PHASE3)
- Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT (PHASE4)
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications (PHASE4)
- Retinoic Acid Homeostasis in Neuropsychiatric Diseases
- Antipsychotic Induced Structural and Functional Brain Changes (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aripiprazole with Clozapine CI brief — competitive landscape report
- Aripiprazole with Clozapine updates RSS · CI watch RSS
- Shanghai Mental Health Center portfolio CI